Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Current assets:
Cash and cash equivalents
Accounts receivable, net
Prepaid expenses and other current assets
Total current assets
Property and equipment, net
Right-of-use assets, net
Other non-current assets
Total assets
Current liabilities:
Accounts payable and accrued expenses
Note payable - stockholder
Accounts payable
Accrued expenses
Deferred revenue
Insurance premium financing payable
Notes payable current, net
Operating lease liability, current
Warrant liability
Total current liabilities
Operating lease liability, non-current
Total liabilities
Redeemable convertible preferred stock; 21,987,039 shares authorized; 0 shares issued and outstanding as of June 30, 2026 and 18,994,952 shares issued and outstanding as of September 30, 2025, Liquidation value of $91,397,911 as of September 30, 2025
Stockholders’ equity (deficit):
Common stock, par value $0.0001; 500,000,000 shares authorized; 48,312,482 and 13,150,921 shares issued and outstanding as of June 30, 2026 and September 30, 2025, respectively
Additional paid-in capital
Accumulated deficit
Total Stockholders’ equity (deficit)
Total liabilities, redeemable convertible preferred stock, and stockholders’ deficit

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support